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Abstract In vitro analyses of varicella zoster virus (VZV)
reactivation from latency in human ganglia have been ham-
pered by the inability to isolate virus by explantation or
cocultivation techniques. Furthermore, attempts to study
interaction of VZV with neurons in experimentally infected
ganglion cells in vitro have been impaired by the presence
of nonneuronal cells, which become productively infected
and destroy the cultures. We have developed an in vitro
model of VZV infection in which highly pure (>95 %)
terminally differentiated human neurons derived from plu-
ripotent stem cells were infected with VZV. At 2 weeks
post-infection, infected neurons appeared healthy compared
to VZV-infected human fetal lung fibroblasts (HFLs), which
developed a cytopathic effect (CPE) within 1 week. Tissue
culture medium from VZV-infected neurons did not produce
a CPE in uninfected HFLs and did not contain PCR-
amplifiable VZV DNA, but cocultivation of infected neu-
rons with uninfected HFLs did produce a CPE. The non-
productively infected neurons contained multiple regions of
the VZV genome, as well as transcripts and proteins
corresponding to VZV immediate-early, early, and late
genes. No markers of the apoptotic caspase cascade were
detected in healthy-appearing VZV-infected neurons. VZV
infection of highly pure terminally differentiated human
neurons provides a unique in vitro system to study the
VZV-neuronal relationship and the potential to investigate
mechanisms of VZV reactivation.
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Introduction
Varicella zoster virus (VZV) is a ubiquitous exclusively
human neurotropic alphaherpesvirus. Primary infection usu-
ally produces varicella (chickenpox), after which virus
becomes latent in ganglionic neurons along the entire neu-
raxis (Gilden et al. 2003). VZV often reactivates decades
later to produce zoster (shingles), characterized by derma-
tomal distribution pain and rash. Zoster may be further
complicated by chronic pain, as well as VZV meningoence-
phalitis, myelopathy, vasculopathy, and retinitis (Gilden et
al. 2011). Prevention of these serious neurological and ocu-
lar complications requires a better understanding of the
VZV–host relationship in infected neurons.
Unlike herpes simplex virus, which is readily recov-
ered by explantation of latently infected human ganglia
in tissue culture or by cocultivation of latently infected
human ganglionic cells with indicator cells, VZV cannot
be recovered from latently infected human ganglia by
these techniques (Plotkin et al. 1977). Thus, attempts
have been made to establish a nonlytic infection of
human neurons in vitro that can be used to study virus
reactivation. Unfortunately, such attempts have been
hampered by the presence in these cultures of
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nonneuronal cells, which become productively infected
and destroy the entire culture. Herein, we report the
successful nonproductive VZV infection of highly pure
(>95 %) terminally differentiated human neurons (iCell
neurons). iCell neurons are derived from induced pluri-
potent stem cells and are a mixture of post-mitotic
neural subtypes, comprised primarily of GABAergic
and glutamatergic neurons, with typical physiological
characteristics and responses and positive staining with
multiple neuronal markers. Weeks after VZV infection,
analyses of healthy-appearing neurons for cell-free and
cell-associated virus, as well as for the presence of VZV
DNA, VZV transcripts, VZV protein, and early and late
markers of apoptosis confirmed the nonproductive
nature of the infection.
Materials and methods
Coating surfaces for neuronal cultures
Tissue culture plates (six wells) (Corning, Tewksbury, MA)
were coated with 1 ml poly-L-ornithine solution (Sigma, St.
Louis, MO) for 1 h, washed twice with sterile water fol-
lowed by addition of 3 ml of 3.3 μg/ml laminin solution
(Sigma) for 1 h at 37 °C, and used immediately.
Cells
iCell neurons (Cellular Dynamics International, Madison,
WI) are derived from induced pluripotent stem cells and
are a mixture of post-mitotic neural subtypes, comprised
primarily of GABAergic and glutamatergic neurons, with
typical physiological characteristics and responses and pos-
itive staining with multiple neuronal markers. iCell neurons
obtained in frozen vials were thawed, seeded at 75,000–
100,000 cells per cm onto coated surfaces and maintained
in fresh iCell complete maintenance medium at 37 °C in 5 %
CO2. Tissue culture medium (75 % of the total volume) was
changed three times per week. Human fetal lung fibroblasts
(HFLs) were cultured in Dulbecco’s minimum essential
medium (DMEM) containing 100 U/ml penicillin and
10 μg/ml streptomycin supplemented with 10 % fetal
bovine serum (FBS).
Virus infection
To minimize any possibility of overwhelming infection,
neurons (∼1×106) were infected with 1,000 pfu attenuated
virus (Zostavax, Merck, Whitehouse Station, NJ) in iCell
complete maintenance medium. HFLs were similarly
infected with 1,000 pfu VZV and maintained in DMEM
supplemented with 2 % FBS.
Attempts to rescue virus from VZV-infected neurons
Two weeks after infection, tissue culture medium from
infected neurons was added to HFLs and cells were moni-
tored for CPE; in addition, 5 μl of 2.5 ml tissue culture
medium was used in real-time PCR with VZVopen reading
frame (ORF) 9- and 63-specific primers. CPE was also
monitored in HFLs cocultivated with infected neurons
released by trypsin treatment and suspended in DMEM.
Total nucleic acid extraction
Total nucleic acid was extracted using the mirVana miRNA
extraction kit (Ambion, Austin, TX). Briefly, cells were
scraped in lysis buffer (Ambion) using a rubber policeman.
If present, visible cell clumps were homogenized using a
17–26-gauge needle with a 1-ml syringe (12–20 strokes)
and kept on ice for 10 min. Total nucleic acid was extracted
with Acid-Phenol:Chloroform and applied to an affinity
column, washed three times, and eluted in 100 μl of PCR-
grade water (Teknova, Hollister, CA) at 95 °C.
Quantitative real-time PCR
Total nucleic acid was examined by quantitative real-time
PCR (RT-qPCR) with VZV-specific primers (IDT,
Coralville, IO) (Table 1) on an Applied Biosystems Fast
7500 Real-Time PCR System and analyzed using Fast 7500
software. Samples were denatured at 95 °C and allowed to
elongate and anneal for 40 cycles at 95 °C for 15 s and at 60 °
C for 30 s. Glyceraldehyde-3-phosphate dehydrogenase
(GAPdH) primers and probe were used as a cellular control.
RNA extraction, cDNA synthesis, and RT-qPCR
Total nucleic acid (200 ng) was DNase-treated using a
Turbo-DNA free kit (Ambion) for 30 min at 37 °C, followed
by inactivation using inactivation buffer (Ambion) for 5 min
at room temperature with mixing. Sequestered DNase was
pelleted by centrifugation at 2,000 rpm for 5 min and the
supernatant was transferred to a new tube. cDNA synthesis
was completed using the Transcriptor First-Strand cDNA
synthesis kit (Roche, Indianapolis, IN). Anchored oligo-
[dT] and random hexamer primers were added and annealed
for 10 min at 65 °C to ensure high conversion of mRNA to
cDNA. After primer annealing, dNTPs, reverse transcriptase
(RT) reaction buffer and RNase inhibitor were added.
Samples were divided into two portions with and without
RT to control for any residual DNA. cDNA was stored at
−80 °C. Both RT-positive and RT-negative samples were
amplified along with wild-type VZV DNA (106 to 100
genome copies) to compare transcription levels to residual
DNA levels. VZV primers (Table 1) and Taq Universal
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Probes superscript ROX mix, (Bio-Rad, Hercules, CA) were
combined with 2 μl of cDNA and added to a MicroAmp 96-
well plate. Quantitative real-time PCR was performed as
described above. GAPdH primers and probe were used as
a cellular control to confirm cDNA synthesis. VZV gene
expression was presented as a Ct ratio to that of GAPdH.
Immunocytochemistry
Coated coverslips used for neuron propagation were
obtained from BD Biosciences (San Jose, California).
Cells were fixed in 4 % paraformaldehyde for 20 min at
room temperature, washed three times in PBS, and permea-
bilized in 0.3 % Triton for 10 min. After three rinses with
PBS, cells were either stained or stored at 4 °C in PBS.
Primary and secondary Alexa Fluor-conjugated (Invitrogen,
Grand Island, NY) antibodies were sequentially added at
dilutions listed in Table 2, followed by rocking for 1 h at
room temperature after each addition. After three washes
with PBS, coverslips were sealed using mounting media
containing DAPI (Vectashield, Vector Labs, Burlingame,
CA) and visualized on an Eclipse E800 microscope
(Nikon, Melville NY).
Results
Human neurons used for infection with VZVare highly pure
iCell neurons were obtained in frozen vials, plated onto
six-well cell culture plates freshly coated with a base
layer of poly-L-ornithine and a top layer of mouse
laminin, and maintained in complete iCell neuron main-
tenance medium for up to 21 days. After 1–3 days in
tissue culture and before VZV infection (day0), neurons
exhibited a homogeneous morphology (Fig. 1a), and
more than 95 % cells stained positive with neuronal
marker βIII tubulin (Fig. 1d).
VZV-infected neurons did not develop CPE
Neurons and HFLs were infected in parallel. A CPE devel-
oped in infected HFLs at 5–7 days post-infection, while
Table 1 Primers/probes for real-time PCR
Name Forward
primer
Reverse
primer
Probe
(FAM)
Size
(bp)
ORF 4 GTTGTCCGTGGCTCTAAATTTG ACATTCAACACGACCACACTC CCTCTAAAACACCGGCCAGACTGA 144
ORF 9 GGGAGCAGGCGCAATTG TTTGGTGCAGTGCTGAAGGA CAATTGCCAGCGGGAGACC 54
ORF 11 GAGCAAGACAGGATAGTTCAGG AAGATTTTCGGCTAGGTCCAC TCCGTTTTGTGGGATTGGAGACAT 117
ORF 28 CGAACACGTTCCCCATCAA CCCGGCTTTGTTAGTTTTGG TCCAGGTTTTAGTTGATACCA 62
ORF 29 GGCGGAACTTTCGTAACCAA CCCCATTAAACAGGTCAACAAAA TCCAACCTGTTTTGCGGCGGC 66
ORF 62 CCTTGGAAACCACATGATCGT AGCAGAAGCCTCCTCGACAA TGCAACCCGGGCGTCCG 79
ORF 63 GCTTACGCGCTACTTTAATGGAA GCCTCAATGAACCCGTCTTC TGTCCCATCGACCCCCTCGG 67
ORF 66 CCACGTTACCGAACAGATTTATACTG GATCGCTGAATTGCTAAAATGTCA CTAGCTGCAAAGCGCAACCTCCCC 83
ORF 68 GTACATTTGGAACATGCGCG TCCACATATGAAACTCAGCCC AAAACAAGAAACCCTACGCCCGC 140
Table 2 Antibodies used for immunocytochemistry
Animal Target protein Dilution Supplier
Mouse VZV IE62 1:500 Novus Biologicals, Littleton, CO
Rabbit VZV IE63 1:1,000 Mahalingam et al. 1996
Rabbit VZV ORF 29 1:500 Cohrs et al. 2002
Goat VZV thymidine kinase 1:200 Santa Cruz Biotech, Santa Cruz, CA
Mouse VZV glycoprotein E 1:500 Santa Cruz Biotech
Mouse VZV glycoprotein H 1:10 Stipan Jonjić, University of Rijeka,
Croatia and Jürgen Haas,
University of Edinburgh, UK
Rabbit Human βIII tubulin 1:1,000 Cell Signaling Technology, Danvers, MA
Mouse Human glial fibrillary acidic protein (GFAP) 1:300 Cell Signaling Technology
Rabbit Human cleaved caspase-3 1:400 Cell Signaling Technology
Rabbit Human cleaved caspase-9 1:400 Cell Signaling Technology
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VZV-infected neurons appeared healthy as did uninfected
neurons 2 weeks later (Fig. 1b, c). Two weeks after infec-
tion, more than 95 % cells still stained positive with anti-
βIII tubulin antibody (Fig. 1e, f).
Examination of VZV-infected neurons for cell-free and cell-
associated virus
HFLs incubated with the tissue culture medium from VZV-
infected neurons did not develop a CPE. Moreover, no VZV
DNA was amplified from the tissue culture medium, indi-
cating the absence of cell-free virus. In contrast, a CPE did
develop in HFLs cocultivated with trypsinized neurons that
had been infected 2 weeks earlier.
VZV DNA and transcripts were present in nonproductively
infected human neurons
Two weeks after infection, multiple regions of the VZV
genome were detected in nonproductively infected neu-
rons (Fig. 2). A search for the presence of VZV tran-
scripts corresponding to immediate-early (IE), early (E),
and late virus genes revealed transcripts corresponding
to VZV ORFs 62, 63, 28, 33, 68, and 31 in infected
neurons; each VZV transcript in neurons was less abun-
dant than in productively infected fibroblasts at the time
of CPE (Fig. 3).
uninfected day 14 14 DPI-VZVday 0
ca b 
d fe
Fig. 1 VZV infection of highly pure human neurons did not produce a
cytopathic effect. Terminally differentiated neurons were maintained in
tissue culture for up to 21 days. Phase-contrast microscopy showed
healthy-appearing neurons on day 0 (a) and day14 in culture (b) as
well as 14 days after VZV infection (c). Dual immunofluorescence
staining (d–f) with anti-βIII-tubulin antibody and anti-GFAP antibody
revealed positive staining for the neuronal marker tubulin (red), but not
for GFAP (green). Nuclei stained blue with DAPI
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Fig. 2 VZV DNA was present in nonproductively infected human
neurons. Two weeks after VZV infection, DNA was extracted from
neurons and quantitated by real-time PCR. Multiple regions of the
VZV genome were detected (black and gray bars are VZVand GAPdH
DNA, respectively)
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Fig. 3 Multiple VZV transcripts were present in nonproductively
infected neurons. Two weeks after infection of neurons, total RNA
was extracted, treated with DNase, and cDNA was synthesized. Tran-
scripts corresponding to VZV immediate-early, early, and late genes
were quantified by qPCR as compared to RNA obtained from VZV-
infected fibroblasts at the height of a cytopathic effect (black and gray
bars are neurons and HFL, respectively)
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Multiple VZV proteins were detected in nonproductively
infected neurons
Two weeks after VZV infection of neurons, two VZV IE
proteins (Fig. 4), two VZV E proteins (Fig. 5), and two
late VZV proteins (Fig. 6) were detected in neurons that
stained positive for βIII tubulin (Fig. 4a, red). VZV IE
62 was present in the nucleus of neurons (Fig. 4a,
green). VZV IE63 was present in both the nucleus and
cytoplasm of infected neurons (Fig. 4b, c, reddish
orange). Dual staining with DAPI (blue) revealed VZV
early ORF 29 protein in the nucleus of neurons (Fig. 5a,
green), while dual staining with DAPI (blue) revealed
ca b 
Fig. 4 VZV immediate-early proteins were present in nonproductively
infected human neurons. Two weeks after VZV infection, neurons
attached to laminin-coated coverslips were fixed and immunostained
with anti-tubulin antibody and anti-VZV IE 62 antibody. Highly pure,
βIII-tubulin-positive human neurons (red, a) contain VZV IE62 in the
nucleus (green). b, c Dual-immunostained neurons: VZV IE62 protein
was seen in the nucleus (green) and VZV IE 63 in the cytoplasm (red).
Scale bar 20 μm
a 
b 
Fig. 5 VZV early proteins were present in nonproductively infected
human neurons. Two weeks after VZV infection, neurons attached to
laminin-coated coverslips were fixed and immunostained with anti-
VZV ORF 29 antibody and anti-VZV thymidine kinase (TK) antibody.
a Dual immunostaining of DAPI and early VZV ORF 29 protein in the
nucleus (green). b Dual immunostaining of DAPI and anti-VZV TK
antibody. VZV TK was seen in the cytoplasm of infected neurons.
Scale bars 20 μm
b 
a 
Fig. 6 VZV late proteins gE and gH were detected in nonproductively
infected human neurons. Two weeks after VZV infection, neurons
attached to laminin-coated coverslips were fixed and immunostained
with anti-VZV gE (a) or anti-VZV gH (b). Dual immunostaining
revealed late VZV gE in the cytoplasm (green, a) and VZV gH in
the cytoplasmic membrane (green, b). Scale bars 20 μm
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VZV early ORF 36 protein (TK) in the cytoplasm of
infected neurons (Fig. 5b, green). Dual staining with
VZV late ORF 68 protein (gE) was seen in the cyto-
plasm of infected neurons (Fig. 6a, green) and VZV ORF
37 protein (gH) in the cytoplasmic membrane of infected
neurons (Fig. 6b, green).
VZV did not induce apoptosis in neurons
Immunostaining analysis of VZV-infected neurons and fibro-
blasts for the active form of caspase-3 and caspase-9 revealed
both caspases in VZV-infected fibroblasts, but neither caspase
in healthy-appearing neurons at 2 weeks after VZV infection
(Fig. 7).
Discussion
Herein, we report nonproductive VZV infection of highly
pure terminally differentiated human neurons, with purity
verified by positive βIII tubulin and negative glial fibrillary
acidic protein (GFAP) staining at the time of VZV infection
as well as 2 and 3 weeks later. Two weeks after VZV
infection, neurons appeared healthy and no CPE developed
compared to HFLs infected at the same dose. Tissue culture
medium removed from neurons 2 weeks after infection did
not produce a CPE in HFLs, and the absence of cell-free
VZV was confirmed by real-time PCR which did not
amplify DNA with VZV-specific primers. In contrast, a
CPE developed in HFLs after cocultivation with VZV-
infected neurons. Rescue of VZV from these neurons is
analogous to the isolation of measles virus in tissue culture
by cocultivaton of brain cells from a patient with subacute
sclerosing panencephalitis with Vero cells (Payne et al.
1969) and isolation of JC virus by cocultivation of brain
cells from a patient with progressive multifocal leukoence-
phalopathy with human fetal brain cells (Padgett et al.
1971). Overall, the detection of VZV DNA corresponding
to multiple regions of the VZV genome, together with the
presence of transcripts and proteins corresponding to
immediate-early, early, and late VZV genes in VZV-
infected neurons that never showed CPE confirms the non-
productive nature of the infection. The absence of both early
and late apoptotic markers indicated that the apoptotic cas-
cade was not operative in neurons nonproductively infected
with VZV.
Numerous attempts have been made to establish a model
of VZV infection both in vitro and in vivo. For example,
infection of partially purified human fetal sensory neurons
with cell-associated VZV showed more CPE in nonneuro-
nal cells than in neurons (Wigdahl et al. 1986). Analysis of
explanted human fetal dorsal root ganglia cocultivated
with human fetal fibroblasts revealed that neurons were
resistant to apoptosis (Hood et al. 2003). In a study using
human neural stem cells from fetal brain transplanted into
nonobese diabetic SCID mouse brain and allowed to differ-
entiate in vivo, VZV was found in both neurons and glial
cells after infection (Baiker et al. 2004). The same group
demonstrated productive VZV infection of human fetal
dorsal root ganglionic explants containing neurons and
nonneuronal cells; VZV infection peaked at day4, but
dropped dramatically by day5 (Gowrishankar et al.
2007). In a study using human dorsal root ganglia
engrafted under the kidney capsule of SCID mice and
infected with VZV, electron microscopy revealed VZ viri-
ons in neuronal cell nuclei and cytoplasm, but not in
satellite cells, and infectious virus was recovered 14 days
after infection; however, 4–8 weeks later, no infectious
virus was released from cells, no virion assembly was
detected, and the number of VZV genome copies was
a 
c 
b 
d 
Fig. 7 Caspase-3 and caspase-
9 proteins were not detected in
VZV-infected neurons. Two
weeks after VZV infection,
neurons attached to laminin-
coated coverslips were fixed
and dual immunostained with
anti-caspase-3 (red) and anti-
VZV 62 (green) or with anti-
caspase-9 (red) and anti-VZV
62 (green) antibodies. a, c VZV
62 protein (green) but not
caspase-3 (red) or caspase-9
(red) in nonproductively
infected neurons. b, d Exten-
sive caspase-3 (red) and
caspase-9 (red) and VZV IE 62
(green) staining in VZV-
infected fibroblasts
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markedly reduced (Zerboni et al. 2005). Infection of neu-
rons derived from human embryonic stem cells with cell-
associated VZV-expressing green fluorescent protein
yielded productive infection although the percent of neu-
rons in the heterogeneous culture was not provided
(Markus et al. 2011), and VZV infection of differentiated
neuroblastoma cells also induced productive infection
(Christensen et al. 2011). In addition, VZV was shown to
infect human embryonic stem cell-derived neurons and
neurospheres, but not pluripotent embryonic stem cells or
early progenitors (Dukhovny et al. 2012). Overall, defini-
tive conclusions cannot be drawn since none of the studies
above was performed in sufficiently pure neuronal cultures.
Meanwhile, our findings herein verify our earlier demonstra-
tion of nonproductive infection of differentiated neurons with-
out evidence of apoptosis (Pugazhenthi et al. 2011). However,
because generation of cultures containing over 90 % neurons
was inconsistent, we began infecting iCell neurons with VZV
to show that infection of highly pure cultures of differentiated
neurons with VZV produces a nonproductive infection in the
absence of apoptosis. This model will allow molecular analy-
sis of virus–neuronal interaction and studies of the mecha-
nisms of VZV reactivation.
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